- |||||||||| NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Tai Chi After Pulmonary Rehabilitation in Patients With COPD: A Randomized Trial (clinicaltrials.gov) - Oct 3, 2018 P=N/A, N=90, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Sep 2018 | Trial primary completion date: Jun 2018 --> Jan 2018
- |||||||||| NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date, Adverse events: Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions (clinicaltrials.gov) - Sep 25, 2018 P=N/A, N=3000, Completed, Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Sep 2018 | Trial primary completion date: Jun 2018 --> Jan 2018 Recruiting --> Completed | Trial completion date: Mar 2018 --> Jan 2017 | Trial primary completion date: Mar 2018 --> Dec 2016
- |||||||||| Biomarker, Trial completion: Biomarkers and Genetic Factors Related to Emphysema (clinicaltrials.gov) - May 4, 2018
P=N/A, N=145, Completed, Active, not recruiting --> Completed | Trial completion date: Sep 2012 --> Dec 2017 | Trial primary completion date: Sep 2012 --> Dec 2017 Active, not recruiting --> Completed
- |||||||||| Trial completion date: IBV (clinicaltrials.gov) - Apr 18, 2018
P=N/A, N=277, Completed, Suspended --> Completed | N=10 --> 24 Trial completion date: Feb 2017 --> Aug 2017
- |||||||||| Biomarker, Trial completion, Enrollment change, Trial primary completion date: Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease (clinicaltrials.gov) - Dec 6, 2017
P=N/A, N=2085, Completed, Trial primary completion date: Aug 2017 --> Sep 2016 Active, not recruiting --> Completed | N=1200 --> 2085 | Trial primary completion date: Jan 2022 --> Jan 2013
- |||||||||| Trial completion, Trial primary completion date: IBV (clinicaltrials.gov) - Nov 14, 2017
P=N/A, N=277, Completed, Phase classification: P2 --> P=N/A | Trial primary completion date: Jul 2017 --> Dec 2018 Active, not recruiting --> Completed | Trial primary completion date: Nov 2017 --> Feb 2011
- |||||||||| Enrollment closed, Trial primary completion date: IBV (clinicaltrials.gov) - Oct 25, 2017
P=N/A, N=277, Active, not recruiting, No safety data was collected after wk 52. Completed --> Active, not recruiting | Trial primary completion date: Mar 2016 --> Nov 2017
- |||||||||| Trial completion, Phase classification, Enrollment change: Endobronchial Valves in Moderate COPD (clinicaltrials.gov) - May 23, 2017
P=N/A, N=7, Completed, Trial primary completion date: Dec 2016 --> Dec 2018 Recruiting --> Completed | Phase classification: P4 --> PN/A | N=10 --> 7
- |||||||||| Phase classification: IBV (clinicaltrials.gov) - May 9, 2017
P=N/A, N=277, Completed, Recruiting --> Completed | Phase classification: P4 --> PN/A | N=10 --> 7 Phase classification: P3 --> P=N/A
- |||||||||| Enrollment change, Trial withdrawal, Stroma: Adipose Derived Cells for Chronic Obstructive Pulmonary Disease (clinicaltrials.gov) - Mar 15, 2017
P=N/A, N=0, Withdrawn, N=2000 --> 628 | Active, not recruiting --> Terminated; Inability to reach desired recruitment goal; Sponsor executed other RCTs N=100 --> 0 | Recruiting --> Withdrawn
- |||||||||| Phase classification, Enrollment change, Trial termination, Trial primary completion date: Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability (clinicaltrials.gov) - Jul 13, 2016
P=N/A, N=103, Terminated, N=400 --> 66 | Recruiting --> Terminated | Trial primary completion date: Mar 2018 --> Jun 2016; lack of enrollment Phase classification: P2 --> P=N/A | N=20 --> 103 | Active, not recruiting --> Terminated | Trial primary completion date: Jul 2016 --> Dec 2012; Funding exhausted.
- |||||||||| Enrollment closed, Enrollment change, Trial primary completion date: A Safety and Feasibility Study of Re-treating Patients With Severe Emphysema With the RePneu LVRC System. (clinicaltrials.gov) - Jun 20, 2016
P=N/A, N=8, Active, not recruiting, Phase classification: P2 --> P=N/A | N=20 --> 103 | Active, not recruiting --> Terminated | Trial primary completion date: Jul 2016 --> Dec 2012; Funding exhausted. Recruiting --> Active, not recruiting | N=12 --> 8 | Trial primary completion date: Jan 2016 --> Sep 2016
- |||||||||| Trial completion, Trial primary completion date: IBV (clinicaltrials.gov) - Apr 14, 2016
P3, N=300, Completed, Recruiting --> Completed | N=120 --> 84 | Trial primary completion date: Dec 2015 --> Mar 2016 Active, not recruiting --> Completed | Trial primary completion date: Oct 2015 --> Mar 2016
|